{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:40:59Z","timestamp":1781840459690,"version":"3.54.5"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Emer Care"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Ondansetron is commonly used to treat vomiting in gastroenteritis, but has a United States Food and Drug Administration black box warning for risk of Q wave to T wave time interval (QT) prolongation. We report 2 pediatric cases of fatal refractory cardiac arrest after administration of ondansetron.<\/jats:p><\/jats:sec><jats:sec><jats:title>Cases<\/jats:title><jats:p>A 10-year-old previously healthy boy presented to the emergency room with gastroenteritis symptoms. After intravenous fluids, morphine, antibiotics, and 2 doses of ondansetron, the patient became unresponsive with agonal respirations and a wide complex tachycardia consistent with ventricular tachycardia. In a second case, an 86-day-old infant with previously unidentified congenital cardiomyopathy presented to our emergency department with gastroenteritis symptoms. The patient received ondansetron and subsequently experienced repeated bouts of supraventricular tachycardia which progressed to ventricular fibrillation. Resuscitation efforts failed in each case, and both patients expired.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Ondansetron can cause dose-dependent QT prolongation effects, which are more clinically relevant when other proarrhythmic elements are present. There is very limited published experience on use of ondansetron in children younger than 2 years. Our 2 cases join 2 previous case reports of death after ondansetron administration for gastroenteritis. The pharmacology of ondansetron's cardiac effects and drug-induced QT prolongation is discussed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients may have hidden risk factors that, together with ondansetron, could result in a proarrhythmic state that could lead to adverse effects, such as arrhythmias. Administration of ondansetron should be individualized and used cautiously in patients with risk factors for arrhythmia.<\/jats:p><\/jats:sec>","DOI":"10.1097\/pec.0000000000000317","type":"journal-article","created":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T11:23:21Z","timestamp":1422357801000},"page":"779-784","source":"Crossref","is-referenced-by-count":15,"title":["Fatal Cardiac Arrest in 2 Children"],"prefix":"10.1097","volume":"32","author":[{"given":"Scott M.","family":"Brenner","sequence":"first","affiliation":[{"name":"From the *Division of General Pediatrics, Section of Pediatric Hospital Medicine, Pediatric Inpatient Services, \u2020Department of Clinical Pharmacy Services, Lehigh Valley Health Network, Allentown, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Boucher","sequence":"additional","affiliation":[{"name":"From the *Division of General Pediatrics, Section of Pediatric Hospital Medicine, Pediatric Inpatient Services, \u2020Department of Clinical Pharmacy Services, Lehigh Valley Health Network, Allentown, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231023","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/000992280204100902","article-title":"Antiemetic use in pediatric gastroenteritis: a national survey of emergency physicians, pediatricians, and pediatric emergency physicians","volume":"41","year":"2002","journal-title":"Clin Pediatr (Phila)"},{"key":"bib3-20231023","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0140-6736(92)93137-C","article-title":"Ondansetron and chest pain","volume":"340","year":"1992","journal-title":"Lancet"},{"key":"bib4-20231023","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/0253-7613.43168","article-title":"Ondansetron induced fatal ventricular tachycardia","volume":"40","year":"2008","journal-title":"Indian J Pharmacol"},{"key":"bib5-20231023","first-page":"e1","article-title":"Administration of ondansetron is associated with lethal outcome","volume":"125","year":"2010","journal-title":"Pediatrics"},{"key":"bib6-20231023","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2165\/00003495-199652050-00010","article-title":"Ondansetron: a review of its pharmacology and preliminary clinical findings in novel applications","volume":"52","year":"1996","journal-title":"Drugs"},{"key":"bib7-20231023","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0952-8180(96)00093-1","article-title":"Pharmacology of serotonin as related to anesthesia","volume":"8","year":"1996","journal-title":"J Clin Anesth"},{"key":"bib8-20231023","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00002018-199818010-00004","article-title":"A risk-benefit assessment of serotonin 5-HT3 receptor antagonists in antineoplastic therapy-induced emesis","volume":"18","year":"1998","journal-title":"Drug Saf"},{"key":"bib9-20231023","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-6147(91)90556-8","article-title":"5-Hydroxytryptamine: a chameleon in the heart","volume":"12","year":"1991","journal-title":"Trends Pharmacol Sci"},{"key":"bib10-20231023","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0022-3565(24)38946-3","article-title":"Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels","volume":"295","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"bib11-20231023","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/CS20030010","article-title":"T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity","volume":"105","year":"2003","journal-title":"Clin Sci"},{"key":"bib12-20231023","first-page":"463","article-title":"Electrocardiographic changes with serotonin antagonist antiemetics: rate of occurrence and clinical relevance","volume":"12","year":"1993","journal-title":"Proc Am Soc Clin Oncol"},{"key":"bib13-20231023","first-page":"433","article-title":"Reversible electrocardiographic interval prolongations following the specific serotonin antagonists ondansetron (OND) and dolasetron mesylate (DM): a possible drug class effect without sequelae?","volume":"13","year":"1994","journal-title":"Proc Am Soc Clin Oncol"},{"key":"bib14-20231023","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1345\/aph.1C510","article-title":"Electrocardiographic and cardiovascular effects of the 5-hydroxytryptamine 3 receptor antagonists","volume":"37","year":"2003","journal-title":"Ann Pharmacother"},{"key":"bib15-20231023","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.109.192704","article-title":"Prevention of torsade de pointes in hospital settings","volume":"121","year":"2010","journal-title":"Circulation"},{"key":"bib16-20231023","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1540-8167.1993.tb01224.x","article-title":"Drug therapy for torsade de pointes","volume":"4","year":"1993","journal-title":"J Cardiovasc Electrophysiol"},{"key":"bib17-20231023","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","article-title":"Drug induced QT prolongation and torsade de pointes","volume":"89","year":"2003","journal-title":"Heart"},{"key":"bib18-20231023","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1540-8167.2004.03534.x","article-title":"Drug-induced torsades de pointes and implications for drug development","volume":"15","year":"2004","journal-title":"J Cardiovasc Electrophysiol"},{"key":"bib19-20231023","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ahj.2007.01.040","article-title":"Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes","volume":"153","year":"2007","journal-title":"Am Heart J"},{"key":"bib20-20231023","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/00000542-200506000-00006","article-title":"Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron","volume":"102","year":"2005","journal-title":"Anesthesiology"},{"key":"bib21-20231023","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/ALN.0b013e31817fd8c8","article-title":"Droperidol and ondansetron-induced QT interval prolongation","volume":"109","year":"2008","journal-title":"Anesthesiology"},{"key":"bib22-20231023","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2036.1997.97269000.x","article-title":"Antiemetic activity of ondansetron in acute gastroenteritis","volume":"11","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"bib23-20231023","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1067\/mem.2002.122706","article-title":"A randomized clinical trial comparing oral ondansetron with placebo in children vomiting from acute gastroenteritis","volume":"39","year":"2002","journal-title":"Ann Emerg Med"},{"key":"bib24-20231023","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1542\/peds.109.4.e62","article-title":"Ondansetron decreases vomiting associated with acute gastroenteritis: a randomized, controlled trial","volume":"109","year":"2002","journal-title":"Pediatrics"},{"key":"bib25-20231023","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1197\/j.aem.2006.05.018","article-title":"Emergency department treatment of viral gastritis using intravenous ondansetron or dexamethasone in children","volume":"13","year":"2006","journal-title":"Acad Emerg Med"},{"key":"bib26-20231023","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1056\/NEJMoa055119","article-title":"Oral ondansetron for gastroenteritis in a pediatric emergency department","volume":"354","year":"2006","journal-title":"N Engl J Med"},{"key":"bib27-20231023","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.annemergmed.2007.09.010","article-title":"The role of oral ondansetron in children with vomiting as a result of acute gastritis\/gastroenteritis who have failed oral rehydration therapy: a randomized controlled trial","volume":"52","year":"2008","journal-title":"Ann Emerg Med"},{"key":"bib28-20231023","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/11537770-000000000-00000","article-title":"Ondansetron dosing in pediatric gastroenteritis","volume":"12","year":"2010","journal-title":"Pediatr Drugs"},{"key":"bib29-20231023","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MPG.0b013e3182132d8d","article-title":"Metoclopramide versus ondansetron for the treatment of vomiting in children with acute gastroenteritis","volume":"53","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"bib30-20231023","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00228-009-0730-8","article-title":"Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1\u201348 months","volume":"66","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"bib31-20231023","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1460-9592.2010.03408.x","article-title":"The effects of droperidol and ondansetron on dispersion of myocardial repolarization in children","volume":"20","year":"2010","journal-title":"Pediatr Anesth"},{"key":"bib32-20231023","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.coc.0000144849.41300.0a","article-title":"The effects of ondansetron and granisetron on electrocardiography in children receiving chemotherapy of acute leukemia","volume":"28","year":"2005","journal-title":"Am J Clin Oncol"},{"key":"bib33-20231023","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00520-007-0338-4","article-title":"Safety of ondansetron loading doses in children with cancer","volume":"16","year":"2008","journal-title":"Support Care Cancer"},{"key":"bib34-20231023","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2044.1997.101-az0098.x","article-title":"Efficacy of ondansetron and metoclopramide for preventing postoperative emesis following strabismus surgery in children","volume":"52","year":"1997","journal-title":"Anaesthesia"},{"key":"bib35-20231023","first-page":"39","article-title":"Prevention of vomiting after general anesthesia for pediatric ophthalmic surgery","volume":"69","year":"2001","journal-title":"AANA J"},{"key":"bib36-20231023","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1213\/01.ANE.0000155261.27335.29","article-title":"A double-blind comparison of intravenous ondansetron and placebo for preventing postoperative emesis in 1- to 24-month-old pediatric patients after surgery under general anesthesia","volume":"101","year":"2005","journal-title":"Anesth Analg"},{"key":"bib37-20231023","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1651-2227.2008.00804.x","article-title":"Prevention of post-operative nausea and vomiting in children\u2014a prospective randomized double-blind study","volume":"97","year":"2008","journal-title":"Acta Paediatr"},{"key":"bib38-20231023","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/10903127.2010.519822","article-title":"Ondansetron is safe and effective for prehospital treatment of nausea and vomiting by paramedics","volume":"15","year":"2011","journal-title":"Prehosp Emerg Care"},{"key":"bib39-20231023","first-page":"38","article-title":"Postoperative nausea and vomiting in infants and young children following urologic surgery","volume":"94","year":"2011","journal-title":"Minn Med"},{"key":"bib40-20231023","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1080\/15563650802304401","article-title":"Obtundation and seizure following ondansetron overdose in an infant","volume":"46","year":"2008","journal-title":"Clin Toxicol"},{"key":"bib41-20231023","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12630-010-9288-2","article-title":"Ventricular tachycardia after ondansetron administration in a child with undiagnosed long QT syndrome","volume":"57","year":"2010","journal-title":"Can J Anesth"},{"key":"bib42-20231023","first-page":"128","article-title":"Neonatal extrapyramidal movements","volume":"37","year":"2008","journal-title":"Pediatr Ann"},{"key":"bib43-20231023","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00003088-199529020-00004","article-title":"Ondansetron clinical pharmacokinetics","volume":"29","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"bib44-20231023","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMcp0706513","article-title":"Long-QT syndrome","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"bib45-20231023","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1213\/ANE.0b013e3182121d57","article-title":"Implications of anesthesia in children with long QT syndrome","volume":"112","year":"2011","journal-title":"Anesth Analg"},{"key":"bib46-20231023","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1553-2712.2010.00960.x","article-title":"The treatment of pediatric gastroenteritis: a comparative analysis of pediatric emergency physicians' practice patterns","volume":"18","year":"2011","journal-title":"Acad Emerg Med"},{"key":"bib47-20231023","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/pds.2063","article-title":"Estimating pediatric inpatient medication use in the United States","volume":"20","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"bib48-20231023","first-page":"425","article-title":"AAP Practice Parameter: The management of acute gastroenteritis in young children","volume":"97","year":"1996","journal-title":"Pediatrics"},{"key":"bib50-20231023","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1097\/MPG.0b013e31816f7b16","article-title":"European Society for Paediatric Gastroenterology, Hepatology, and Nutrition\/European Society for Paediatric Infectious Diseases Evidence-based guidelines for the management of acute gastroenteritis in children in Europe","volume":"46","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"bib52-20231023","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MOG.0b013e32835a352f","article-title":"Hospital management of children with acute gastroenteritis","volume":"29","year":"2013","journal-title":"Curr Opin Gastroenterol"},{"key":"bib56-20231023","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jamapediatrics.2013.4906","article-title":"Impact of increasing ondansetron use on clinical outcomes in children with gastroenteritis","volume":"168","year":"2014","journal-title":"JAMA Pediatr"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006565-201611000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T21:00:11Z","timestamp":1747515611000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006565-201611000-00008"}},"subtitle":["Possible Role of Ondansetron"],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000000317","relation":{},"ISSN":["1535-1815","0749-5161"],"issn-type":[{"value":"1535-1815","type":"electronic"},{"value":"0749-5161","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}